---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-22-027006"
form_type: "8-K"
ticker: "TERN"
cik: "0001831363"
company_name: "Terns Pharmaceuticals, Inc."
filed_at: "2022-12-23T23:59:59+00:00"
generated_at: "2026-06-20T23:32:27.467854+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Terns Pharmaceuticals prices $75M public offering of 10.35M shares at $7.25

## Summary
- Underwritten offering of 10,350,000 shares at $7.25 per share; gross proceeds ~$75M.
- Underwriters' option for 1,552,500 additional shares exercised in full; net proceeds ~$80.8M.
- Proceeds to advance TERN-501, TERN-701, and TERN-601 clinical programs and for working capital.
- Lead book-runners: Jefferies and Cowen; co-managers: UBS, Mizuho, JMP Securities.
- Offering priced Dec 20, 2022; closed Dec 23, 2022.

## SEC filing metadata
- accession: 0000950170-22-027006
- form_type: 8-K
- ticker: TERN
- cik: 0001831363
- company_name: Terns Pharmaceuticals, Inc.
- filed_at: 2022-12-23T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1831363/000095017022027006/0000950170-22-027006-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1831363/000095017022027006/tern-20221220.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-22-027006
- JSON: https://secwatch.observer/filing/0000950170-22-027006.json
- Plain text: https://secwatch.observer/filing/0000950170-22-027006.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.